Annie Neild
General Counsel bei FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Aktive Positionen von Annie Neild
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | General Counsel | 01.03.2021 | - |
Karriereverlauf von Annie Neild
Ehemalige bekannte Positionen von Annie Neild
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | General Counsel | 01.01.2020 | 01.07.2020 |
Ausbildung von Annie Neild
| Yale University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Niederlande | 2 |
Operativ
| General Counsel | 2 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Health Technology |
- Börse
- Insiders
- Annie Neild
- Erfahrung
